Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc.filedCriticalPfizer Inc.
Publication of YU176590ApublicationCriticalpatent/YU176590A/sh
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions
(AREA)
Abstract
Opisani su novi N-aril- i N-heteroarilamid i karbamid derivati, jedinjenja formule I njihove farmaceutski prihvatljive soli, u kojoj Q i R1 su kao što je ovde gore definisano, i nove karboksilne kiseline i kiselinski halidni intermedijeri koji se upotrebljavaju za sinteze tih jedinjenja. Jedinjenja formule I su inhibitori acil koenzima A. holesterol aciltransferaza (ACAT) i ista se upotrebljavaju kao hipolipidemička i antiarterosklerotička sredstva.
YU176590A1989-09-151990-09-14Novi n-aril i n-heteroarilamid i karbamid derivati kao inhibitori acil koenzima a: holesterol acil transferaza (acat)
YU176590A
(sh)